Pharma

Latest posts

Public funding but private profits - how to fight the pharmaceutical industry on your campus


22 February 2018

Forbes - the American business magazine  - showed that the Pharmaceutical industry was the world's most profitable industry in 2016, with a massive 30% profit for pharmaceutical companies selling generic medicines during that year

It’s #WorldCancerDay, lets fight for affordable cancer drugs


04 February 2018

Access to cancer drugs plays a big part in the fight to save millions of preventable deaths each year. But as our chronically underfunded NHS buckles under pressure this winter, billions of pounds are handed over to pharmaceutical companies every year for overpriced medicines.

Why we can’t trust billionaires with our health


25 October 2017

Morten Thaysen introduces our new campaign against the corporate control of medicine.

Latest news

Campaign groups Global Justice Now and STOPAIDS have welcomed a statement by NHS England to the BBC’s 5 Live Investigates this morning that “further regulatory action may be needed” on drug pricing at a time when NHS funding is under severe pressure.

Treatments for cancer, arthritis and multiple sclerosis (MS) are among drugs costing the cash-strapped NHS over a billion pounds a year – despite public funding playing a substantial role in the medicines’ development.

Resources

A guide to university campaigning for affordable medicine

February 2018

Sick of Corporate Greed: The fight for affordable medicines on your campus is an action guide to help students campaign and affect change. This pack has been made for university students as they are in a prime position to campaign on campus and affect change through targeting their university.

Sick of corporate greed leaflet

November 2017

Pharmaceuticals campaign leaflet

Imagine if the NHS couldn’t afford to save your life

November 2017

All over the world, drug companies are charging extortionate prices for medicine, preventing people accessing treatment.
It’s time to put people before profit in the global drug industry.